Stock Scorer

SOLVONIS THERAPEUTICS PLC (SVNS.L)

Every figure this model derived for SVNS.L, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2024-12-31
cash 1,720,000 CashAndCashEquivalents 2026-01-01
current assets 1,918,000 CurrentAssets 2026-01-01
current liabilities 480,000 CurrentLiabilities 2026-01-01
equity 6,191,000 Equity 2026-01-01
interest expense 0 FinanceCosts 2025-12-31
ocf -3,273,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 0 Revenue 2025-12-31
sbc 559,000 AdjustmentsForSharebasedPayments 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up SVNS.L on one particular measure came for.

RatioValue
current ratio4.0
current ratio reported4.0
ev owner earnings-1.61
roic-99.75

What to be careful about

What this model itself distrusts about SVNS.L's figures. Written by the derivation as it ran, not added afterwards.